|
2024
|
Invention
|
Anti-influenza virus composition containing xanthan gum or fucoidan. The present invention relate... |
|
|
Invention
|
Solid dispersion comprising poorly soluble donepezil salt and method for preparing same. The pres... |
|
|
Invention
|
Novel heterocyclic amine derivatives and pharmaceutical composition comprising same. 112233 are a... |
|
|
Invention
|
Novel heterocyclic compounds and pharmaceutical composition comprising the same as dna polymerase... |
|
|
Invention
|
Manufacturing method for 4-methoxypyrrole derivatives. The present invention relates to a manufac... |
|
2023
|
Invention
|
Pharmaceutical composition comprising enavogliflozin and metformin. The present invention relates... |
|
|
P/S
|
Medicines for veterinary purposes; nutritional supplements for animal foodstuffs; protein supplem... |
|
|
P/S
|
Medicines for veterinary purposes; nutritional supplements
for animal foodstuffs; protein supple... |
|
|
Invention
|
Controlled release pharmaceutical composition. The present invention relates to a formulation cap... |
|
|
Invention
|
Device for nasal administration of drug. The present invention relates to a device for nasal admi... |
|
|
Invention
|
Method for purifying tgf-β3 protein. The present invention relates to a pretreatment method for i... |
|
|
Invention
|
Pharmaceutical composition for preventing or treating nephritis. The present invention provides a... |
|
|
Invention
|
Pharmaceutical composition for prevention or treatment of nephropathy and/or diabetes mellitus, c... |
|
|
Invention
|
Pharmaceutical composition comprising enavogliflozin for preventing or treating cardiovascular ag... |
|
|
Invention
|
Novel co-crystal of enavogliflozin. infinf) and thus can be usefully employed for various indicat... |
|
|
Invention
|
Novel crystalline form of enavogliflozin, and preparation method therefor. The present invention ... |
|
|
Invention
|
Pharmaceutical composition comprising metabolite of enavogliflozin, and use thereof. The present ... |
|
|
Invention
|
Composition containing niclosamide with improved bioavailability. The present invention relates t... |
|
|
Invention
|
Novel genomic safe harbor and use thereof. The present invention relates to a novel genomic safe ... |
|
|
P/S
|
Pharmaceutical preparations for treating diabetes;
pharmaceutical preparations for treating meta... |
|
|
P/S
|
Pharmaceutical preparations for health care; nutritional
supplements for animal foodstuffs; anim... |
|
|
Invention
|
Arginase inhibitor and pharmaceutical composition comprising same. The present invention relates ... |
|
|
Invention
|
Potassium-competitive acid blockers for the treatment of pathological hypersecretory conditions. ... |
|
|
Invention
|
Pharmaceutical composition comprising enavogliflozin for preventing or treating obesity in canine... |
|
|
Invention
|
Novel aminobenzene derivative having cancer cell growth inhibitory effect, and preventive or ther... |
|
|
Invention
|
Method for producing intermediate useful for synethesis of sglt inhibitor. The present invention ... |
|
2022
|
Invention
|
Pharmaceutical composition for preventing or treating triple-negative breast cancer. The present ... |
|
|
Invention
|
Novel acid addition salt and crystalline form of (2r,3s)-2-(3-(4,5-dichloro-1h-benzo[d]imidazol-1... |
|
|
Invention
|
Method for preparation of (2r, 3s)-2-(benzo[d]imidazolylpropyl)piperidin-3-ol derivatives. The pr... |
|
|
Invention
|
Dosage regimen for fexuprazan injection composition.
The present invention provides an appropria... |
|
|
Invention
|
Dosage regimen for fexuprazan injection composition. The objective of the present invention is to... |
|
|
Invention
|
Emulsion homogenization apparatus and method for manufacturing sustained-release microspheres hav... |
|
|
Invention
|
Pharmaceutical composition comprising enavogliflozin. The present invention relates to a pharmace... |
|
|
Invention
|
Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-... |
|
|
Invention
|
Pharmaceutical composition for preventing or treating systemic sclerosis.
The pharmaceutical com... |
|
|
Invention
|
Pharmaceutical composition for preventing or treating systemic sclerosis. A pharmaceutical compos... |
|
|
Invention
|
Pharmaceutical composition for prevention or treatment of systemic sclerosis. A pharmaceutical co... |
|
|
Invention
|
Medicine container comprising liquid pharmaceutical composition of 1-(5-(2,4-difluorophenyl)-1-((... |
|
|
Invention
|
New formulation for injection comprising 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4... |
|
|
Invention
|
Pharmaceutical composition for preventing or treating diabetes mellitus in animal of family canid... |
|
|
Invention
|
Pharmaceutical composition for preventing or treating fibrosis.
The present disclosure relates t... |
|
|
Invention
|
Pharmaceutical composition for preventing or treating fibrosis.
The pharmaceutical composition a... |
|
|
P/S
|
Pharmaceutical agents affecting digestive organs; medicines for treating intestinal disorders; Ph... |
|
|
P/S
|
Preparations for the treatment of hyperlipidemia;
pharmaceutical preparations for the treatment ... |
|
|
P/S
|
Pharmaceutical agents affecting digestive organs; medicines
for treating intestinal disorders; p... |
|
|
P/S
|
Pharmaceutical agents affecting digestive organs for the treatment of gastroesophageal reflux dis... |
|
2021
|
Invention
|
Pharmaceutical composition of single dosage form for treating or preventing hypertension and hype... |
|
|
P/S
|
Botulinum toxin for medical use for use in the treatment of glabellar lines, muscular rigidity, b... |
|
|
P/S
|
Pharmaceutical products for the treatment of infectious
diseases; vaccines against flu; veterina... |
|
|
Invention
|
Method for preparation of heterocyclicamine derivatives.
The present disclosure relates to a met... |
|
|
Invention
|
Intermediate useful for synthesis of sglt inhibitor and method for preparing sglt inhibitor using... |
|
2020
|
Invention
|
Liquid pharmaceutical composition of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-met... |
|
|
Invention
|
Method for preparation of mesenchymal stem cell from human pluripotent stem cell and mesenchymal ... |
|
|
Invention
|
Novel triazolopyridine derivatives and pharmaceutical composition comprising same.
The present i... |
|
|
Invention
|
Synthesis method for preparing sglt inhibitor intermediate.
A method for preparing compound 1 an... |
|
|
Invention
|
Niclosamide delayed-release composition and antiviral use thereof.
The present invention relates... |
|
|
P/S
|
Preparations for the treatment of hyperlipidemia; preparations for the treatment of cardiovascula... |
|
2018
|
P/S
|
Pharmaceutical agents affecting sensory organs;
pharmaceutical agents affecting peripheral nervo... |
|
2015
|
P/S
|
pharmaceutical preparations for hyperlipidemia therapy; pharmaceutical preparations for hypertens... |
|
2013
|
P/S
|
Botulinum toxin; pharmaceuticals; medicines for sensory
organs; medicines for peripheral nervous... |
|
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
P/S
|
Botulinum toxin; Pharmaceuticals, Medicines for sensory organs, Medicines for peripheral nervous ... |
